Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Acq. announced
Consulting agrmnt
Director departure
Inv. presentation
Notes underwriting agrmnt

Cord Blood America, Inc. (CBAI) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2022 REVOKED Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]:
09/23/2020 8-K Quarterly results
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/26/2020 8-K Quarterly results
06/16/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "CBA FLORIDA, INC. ANNOUNCES INITIAL CASH LIQUIDATING DISTRIBUTION $0.0062 per share to be paid on or about June 30, 2020 LAS VEGAS, NV / ACCESSWIRE / June 16, 2020 / CBA Florida, Inc. today announced that its Board of Directors has approved an initial liquidating cash distribution of $0.0062 per share. The distribution will be paid on or about June 30, 2020. The Board has fixed the close of business on June 26, 2020 as the record date for determining shareholders entitled to receive the initial liquidating distribution. The Company intends to file articles of dissolution with the Florida Department of State Division of Corporations on June 26, 2020, the record date for the initial liquidating distribution. In connection with the effectiveness of the articles of dissolution, CBAI will clos..."
06/02/2020 8-K Submission of Matters to a Vote of Security Holders
05/14/2020 10-Q Quarterly Report for the period ended March 31, 2020
05/08/2020 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2020 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/25/2020 10-K Annual Report for the period ended December 31, 2019
03/25/2020 PRE 14A Form PRE 14A - Other preliminary proxy statements:
02/13/2020 8-K Quarterly results
11/15/2019 10-Q/A Quarterly Report for the period ended September 30, 2019 [amend]
11/14/2019 10-Q Quarterly Report for the period ended September 30, 2019
05/15/2019 10-Q Quarterly Report for the period ended March 31, 2019
04/01/2019 10-K Annual Report for the period ended December 31, 2018
11/14/2018 10-Q Quarterly Report for the period ended September 30, 2018
08/14/2018 10-Q Quarterly Report for the period ended June 30, 2018
08/14/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CBA Florida, Inc. Provides 2018 Second Quarter Update LAS VEGAS, NV / ACCESSWIRE / August 14, 2018 / CBA Florida, Inc. today announced an update for the second quarter ended June 30, 2018. Highlights Include: ● The Company completed its previously announced sale of assets to California Cryobank Stem Cell Services LLC on May 17, 2018. ● The Company is discontinuing the issuance of earnings releases given it has no continuing business operations, but the Company will continue to make required filings with the Securities and Exchange Commission including its Form 10-Q for the quarter ended June 30, 2018 which will be filed today. Commentary Chairman David Sandberg stated, "After consultation with external accounting and legal advisors, the Board has determined to wait until 201..."
05/31/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Articles of Amendment to Articles of Incorporation"
05/29/2018 8-K Submission of Matters to a Vote of Security Holders
05/25/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Articles of Amendment to Articles of Incorporation"
05/17/2018 8-K Completion of Acquisition or Disposition of Assets, Departure of Directors or Certain Officers; Election of Directors; Appoin...
Docs: "Articles of Amendment to Articles of Incorporation of Cord Blood America, Inc",
"Investor Contact:"
05/15/2018 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Investor Contact:"
05/14/2018 10-Q Quarterly Report for the period ended March 31, 2018
05/14/2018 8-K Quarterly results
Docs: "Cord Blood America, Inc. Reports 2018 First Quarter Results May 14, 2018 - Cord Blood America, Inc. today announced financial results for the first quarter ended March 31, 2018. Given the agreement entered into with California Cryobank Stem Cell Services LLC to sell substantially all of the Company’s assets, the operating results associated with the assets being sold have been reclassified into discontinued operations and the assets and liabilities are reflected as held-for-sale. Additional disclosure pertaining to this financial treatment is included in the Company’s 10-Q which is being filed today. Highlights Include: ● Total revenue from discontinued operations for the first quarter 2018 was $0.70 million, a decrease of 5.8% from total revenue of $0.75 million for the first quar..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy